High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

People Living Together Share More Oral and Gut Microbiota

People with close family ties who live together share more oral and gut microbes with each other than with other people in their communities.

National AI Initiative Promising for Canadian Healthcare

Canada's new national AI strategy, "AI for All," aims to build trust, expand opportunities, and ensure that AI is used responsibly in healthcare and other industries.

Vitamin K2 Supplementation May Curb Coronary Calcification

Supplementation with vitamin K2 may help slow the progression of coronary artery calcification among people with mild coronary artery disease.

Post-Deprescribing, Do Older Adults Get Inappropriate Meds?

When substitutions occur, more than 1 in 4 involve a potentially inappropriate medication.

WHO Urges Europe to Strengthen Preparedness for Extreme Heat

Updated WHO guidance urges clinicians and health systems to identify vulnerable individuals early and strengthen prevention before extreme heat drives illness and death.

How Donors Died May Not Matter for Heart Transplant Outcomes

Recipients of heart transplants have similar 10-year survival and graft health outcomes, regardless of whether hearts are obtained from donors after circulatory death or brain death, a study finds.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Latest News

People with close family ties who live together share more oral and gut microbes with each other than with other people in their communities.

Canada's new national AI strategy, "AI for All," aims to build trust, expand opportunities, and ensure that AI is used responsibly in healthcare and other industries.

Supplementation with vitamin K2 may help slow the progression of coronary artery calcification among people with mild coronary artery disease.

When substitutions occur, more than 1 in 4 involve a potentially inappropriate medication.

Updated WHO guidance urges clinicians and health systems to identify vulnerable individuals early and strengthen prevention before extreme heat drives illness and death.

Recipients of heart transplants have similar 10-year survival and graft health outcomes, regardless of whether hearts are obtained from donors after circulatory death or brain death, a study finds.

News All Time

Why Does the Heart Rarely Develop Cancer?

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

Inpatient Rehab Underutilized After Stroke, TBI

Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.

New Vericiguat Analysis Shows Hidden Benefits in HF

Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.

Menopause Age Linked to Higher Hypercholesterolaemia Burden

Women experience a significant increase in hypercholesterolaemia diagnoses and related comorbidities around the menopausal transition compared with men.

Early Treatment Cuts Heart Risk in Hypercholesterolaemia

Early treatment of FH in childhood and adolescence may reduce lifetime cholesterol burden and lower the cardiovascular risk compared to treatment starting later in adulthood.

Metyrapone Reduces BP in Mild Autonomous Cortisol Secretion

Evening metyrapone treatment reduces blood pressure at the supine position and epicardial fat in patients with mild autonomous cortisol secretion.

Ultraprocessed Foods: A Factor in Male Fertility Decline?

Emerging evidence links heavily processed dietary patterns to poor semen quality and hormonal changes that may influence reproductive health.

New Atrial Fibrillation May Speed Kidney Decline in Adults

In working-age adults, new-onset atrial fibrillation is linked to a faster decline in kidney function and a substantially higher risk of experiencing a 30% or greater reduction in kidney function.

Gene Therapy Appears to Be Safe in FA Cardiomyopathy

Intravenous gene therapy delivering the frataxin gene appears safe and is associated with preliminary signs of reduced heart damage in patients with Friedreich ataxia cardiomyopathy.

Glycemic Benefits of Testosterone Therapy Wane After 2 Years

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement after 2 years without ongoing lifestyle modification.

Surgery May Extend Survival in EGFR-Mutated Lung Cancer

Surgical removal of residual tumour during TKI therapy may improve survival in patients with epidermal growth factor receptor-mutated non-small cell lung cancer.

AI's 'Blind Trust' Problem Puts Patients at Risk

Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.

Closing the Women's Health Gap With AI and Better Data

From cardiac misdiagnosis to an 8-year wait for endometriosis, experts at HLTH Europe lay out how AI and multimodal data can start closing the gender health gap.

Protein and Creatine Supplements Are No Longer Niche

The fitness supplements have gone mainstream. How much is too much? How should GLP-1 patients use them? Will creatine save our brains? Here’s what the science says.

GLP-1s Tied to Higher Risk for Dizziness, Fainting for Some

Hypotension-related events increased after starting GLP-1s in patients taking multiple antihypertensive medications.

Phase 3 HCM Drug Offers Promising Results in Exercise Tests

Treatment with aficamten may improve multiple measures of exercise in patients with obstructive hypertrophic cardiomyopathy, a study finds.

Recommended News For You

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

Study finds higher breast cancer rates in areas with more air pollution

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

An effective treatment for a rare but deadly form of cancer

Certain surgical gestures during prostate removal linked to better sexual function recovery

More pain, more gain? New biopsy technique found to improve prostate cancer detection

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

Recommended Articles For You

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies 

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care? 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Contemporary Pathways in Hematology and Patient Outcomes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

2.

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

3.

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

4.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

5.

Adult overdose deaths on the rise

1.

Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy

2.

Radiation in Oncology: Advances, Applications, and Accessibility

3.

Environmental Carcinogen Avoidance in Precision Prevention

4.

Unlocking Life Expectancy After Subdural Hematoma: A New Hope

5.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Understanding the causes of anemia in adults beyond nutritional deficiencies

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Thromboprophylaxis In Medical Settings

4.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot